【Exhibition Preview】July 25-28, AM Biotech to Showcase Innovative Technologies, Ingredients, and New Products at the Asia Healthcare & Medical Cosmetology Expo 2024

Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration

Can Exosomes Also Treat Dry Eye Syndrome?!

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular

Bio-Pulsed Exosome with innovative patented technology from AM Biotech to restore health and beauty

Ascension Medical Biotechnology company(AM Biotech) from Taiwan focusing on the research and development of induced

The Emergent Role of Exosome Therapy in 2021

Exosomes are extracellular vesicles (EV) derived from endosomes, ranging in size from 30nm to 150nm.

The Therapeutic Potential of Exosomes

In recent years, several universities and research hospitals have conducted small-scale phase I clinical trials